During the past decade, Praxiszentrum Alte Mälzerei conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Praxiszentrum Alte Mälzerei" #1 collaborator was "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Praxiszentrum Alte Mälzerei" are "Crohn's Disease" (2 trials), "Ulcerative Colitis" (2 trials), "Inflammatory Bowel Diseases" (1 trials) and "Ulcerative Colitis and Crohn's Disease" (1 trials). Many other conditions were trialed in "Praxiszentrum Alte Mälzerei" in a lesser frequency.

Most popular intervention types in "Praxiszentrum Alte Mälzerei" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "CT-P13" (1 trials), "Guselkumab" (1 trials), "Guselkumab Dose 1" (1 trials) and "Guselkumab Dose 2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Praxiszentrum Alte Mälzerei" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Praxiszentrum Alte Mälzerei". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Praxiszentrum Alte Mälzerei, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Praxiszentrum Alte Mälzerei, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".